GetPortalImpactFactorByIdResp(projectId=1, id=62a85972, cover=null, fullname=radiation oncology investigations, abbr=RADIAT ONCOL INVEST, pyear=暂无数据, frequence=null, articleNumbers=0, citedSelf2015=null, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=暂无数据, reviewFee=null, pageFee=null, publishedRatio=2018年中国人文章占该期刊总数量暂无数据 (2017年为暂无数据), issn=1065-7541, greenSci=https://www.greensci.net/search?kw=1065-7541, scijournal=https://www.scijournal.org/impact-factor-of-RADIAT-ONCOL-INVEST.shtml, medsciHotlightString=null, medsciHotlightRealtime=0.598, medsciHotlight=0.609, medsciHotlight5year=0.583301, citescore=0.0, hIndex=0, impactFactor=null, orgnization=John Wiley & Sons Inc., orgnizationUrl=http://www.interscience.wiley., country=United States, countryCn=美国, isOa=null, isOaString=不清楚, sciScie=null, bigclassCas=null, smallclassCas=, website=null, websiteHits=1713, guideForAuthor=null, guideForAuthorHits=6, submitWebsite=, submitWebsiteHits=2, content=Radiation Oncology Investigations: Clinical and Basic Research aims at improved rapid communication of expanding research in radiation oncology and the related specialties of radiobiology cancer biology and medical physics. The journal focuses on investigational aspects of clinical and basic research related to radiotherapy and gives priority to the publication reporting on translational research i.e. laboratory observations with significant implications for clinical radiotherapy and clinical studies that indicate new approaches for basic research. As we can expect significant impact from the improved understanding of molecular mechanisms underlying cellular radiation responses the journal also covers the evolving field of molecular radiobiology. The journal provides a means of communication of important radiotherapy treatment delivery innovations from both the technical and trial design perspective. There is also interest in clinical trials that use novel forms of radiotherapy either alone or in combination with other cancer treatment modalities., totalCites=null, brief=RADIAT ONCOL INVEST杂志医学行业，“<strong><a target="_blank" href="/sci/index.do?smallclass=肿瘤学" >肿瘤学</a></strong>”子行业的级别不明杂志, articleType=本刊接收类型不明, medsciHeat=<span style="color: #000000;">黑</span>, medsciComment=杂志水平一般，也很冷门，关注人少，审稿周期可能也不一定快，如果文章质量不佳，或时间不紧的话，可以考虑考虑。, medsciExplanation=MedSci期刊指数是根据中国科研工作者（含医学临床，基础，生物，化学等学科）对SCI杂志的认知度，熟悉程度，以及投稿的量等众多指标综合评定而成。当然，具体的，您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=62a85972'>投稿经验系统</a>”，进行综合判断，这更是大家的实战经验，值得分享和参考。<br> 注意，上述MedSci期刊指数采用MedSci专利技术，由计算机系统自动计算，并给出建议，存在不准确的可能，仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=119, tagName=肿瘤, createdHits=1), ImpactFactorTagDto(id=516, tagName=癌症, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2012, citescore=0.0), GetImpactFactorCiteScoreListResponse(year=2013, citescore=0.0), GetImpactFactorCiteScoreListResponse(year=2014, citescore=0.0)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2019, medsciHotlight=1.17), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=0.629), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=0.56), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=0.877), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=0.598)], citeScoreGradeList=[], totalJcrAreaList=[], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1065-7541[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=radiation oncology investigations[ta], article_number=0, article_number_cn=null, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)